Who Buys Dapsone from India — 178 Importers Behind a $22.6M Market
India's dapsone import market is served by 178 active buyers who collectively imported $22.6M across 1,279 shipments. TORRENT PHARMA INC (UNITED STATES) leads with a 43.2% market share, followed by TORRENT PHARMA INC, and TORRENT PHARMA INC C/O,. The top 5 buyers together control 77.4% of total import value, reflecting a concentrated buyer landscape.
Dapsone buyer data — 178 importers · $22.6M market · 1,279 shipmentsTransData Nexus · Indian Customs Data
Top Dapsone Importers — Ranked by Import Value
TORRENT PHARMA INC (UNITED STATES) is the leading dapsone importer from India, holding a 43.2% share of the $22.6M market across 1,279 shipments from 178 buyers. The top 5 buyers — TORRENT PHARMA INC (UNITED STATES), TORRENT PHARMA INC, (UNITED STATES), TORRENT PHARMA INC C/O, (UNITED STATES), MARCAN PHARMACEUTICALS INC. (CANADA), J. KNIPPER & COMPANY (UNITED STATES) — collectively control 77.4% of total import value.
Top Dapsone Buyers & Importers
Ranked by import value · 178 active buyers · Indian Customs (DGFT) data
Mar 2026
Top Dapsone Buyers & Importers — Ranked by Import Value. 178 active buyers with import value, shipments, country and supplier data compiled from Indian Customs records by TransData Nexus.
PHARMACEUTICALS PRODUCTS ACNEDAP GEL DAPSONE 15GMPHARMACEUTICAL PRODUCTS ACNEDAP GEL DAPSONE 15GMPHARMACEUTICALS PRODUCTS ACNEDAP PLUS GEL DAPSONE 15GM
$118.2K
150
5
0.5%
14
IPD, SC, USAUNITED STATES
DAPSONE GEL 7.5%,60GMDAPSONE GEL 7.5%,60GM NOSDAPSONE 7.5%, GEL 60GM (NDC CODE
Which companies are buying Dapsone — and from which countries?
Flow of Dapsone exports from India: each country's share and the named importers behind the numbers
Dapsone — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Top 5 importing countries account for 99.1% of global Dapsone imports — led by United States (86.8%) with a total trade value of $22.6M across 1,279 shipments from India.
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $19.6M through 75 shipments. This represents a market share of 86.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• TORRENT PHARMA INC - $9.8M (49.8% of country's total business)
• TORRENT PHARMA INC, - $3.8M (19.4% of country's total business)
• TORRENT PHARMA INC C/O, - $1.6M (8.2% of country's total business)
• J. KNIPPER & COMPANY - $1.1M (5.7% of country's total business)
• TORRENT PHARMA INC C O - $752.3K (3.8% of country's total business)
• Rest of United States's importers - $2.5M (13.0% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $261.5K, indicating premium pricing strategy compared to the market average of $17.7K.
United States is a key market for Dapsone imports, representing 86.8% of total trade value.
Primary Market
Secondary Market
Buyer Segment Analysis
TransData Nexus Dapsone buyer market intelligence
1Buyer Segment Analysis
The importation of Dapsone from India involves various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like J. Knipper & Company and Eversana Life Science Services in the United States fall into this category. They procure Dapsone in bulk to supply pharmacies, hospitals, and healthcare providers. Their purchasing patterns are characterized by large, regular orders to maintain a steady supply chain.
Contract Manufacturers: Torrent Pharma Inc., a significant buyer from the United States, exemplifies this segment. They import Dapsone as an active pharmaceutical ingredient (API) for formulation into finished products. Their procurement is typically large-scale and consistent, aligning with production schedules and market demand.
Retail Chains and Hospital Groups: Marcan Pharmaceuticals Inc. in Canada represents this segment. They import Dapsone to distribute across their network of pharmacies and healthcare facilities. Their purchasing behavior includes regular, moderate-sized orders to meet the needs of their clientele.
Government Procurement: While not explicitly listed among the top buyers, government agencies and international organizations often procure Dapsone through tenders for public health programs. Their purchasing is characterized by large, periodic orders based on public health needs and budget allocations.
Country-Specific Import Regulations
TransData Nexus Dapsone buyer market intelligence
1Country-Specific Import Regulations
Import regulations for Dapsone vary across the top importing countries:
United States:
Regulatory Authority: Food and Drug Administration (FDA).
Import Registration Process: Importers must ensure that Dapsone is FDA-approved and complies with the Federal Food, Drug, and Cosmetic Act. This includes proper labeling, manufacturing standards, and adherence to the Drug Supply Chain Security Act.
Estimated Timeline for Registration: The FDA's drug approval process can take several months to years, depending on the complexity of the application and whether it's a new drug application (NDA) or an abbreviated new drug application (ANDA).
Import Tariff/Duty: According to the Harmonized Tariff Schedule of the United States (HTSUS), Dapsone falls under subheading 3004.90.9214, which is duty-free.
Canada:
Demand Drivers & Market Opportunity
TransData Nexus Dapsone buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Dapsone in importing countries is influenced by several factors:
Disease Prevalence: Dapsone is primarily used to treat leprosy and dermatitis herpetiformis. According to the World Health Organization (WHO), in 2024, there were approximately 200,000 new cases of leprosy reported globally, with significant numbers in countries like India, Brazil, and Indonesia.
Government Healthcare Programs: Many countries have national programs aimed at eradicating leprosy and managing other skin conditions, which include the provision of Dapsone. For instance, the National Leprosy Eradication Programme in India has been instrumental in reducing the disease burden.
Universal Health Coverage Expansion: The global push towards universal health coverage has led to increased access to essential medicines, including Dapsone. Countries expanding their healthcare services are incorporating such medications into their formularies.
WHO Essential Medicines List Procurement: Dapsone is listed on the WHO Model List of Essential Medicines, guiding countries in their procurement decisions. This inclusion underscores its importance and encourages its availability in public health systems.
Common Questions — Dapsone Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest dapsone buyer importing from India?
Based on import volume and value, TORRENT PHARMA INC (UNITED STATES) leads with $9.8M in imports and a 43.2% market share — the highest of any single dapsone importer. TORRENT PHARMA INC, (UNITED STATES) and TORRENT PHARMA INC C/O, (UNITED STATES) are the next largest buyers.
QHow many companies buy dapsone from India?
There are 178 active dapsone buyers importing from India, with a combined market of $22.6M across 1,279 shipments to 55 countries. The top 5 buyers hold 77.4% of total import value, while the remaining 173 buyers handle the other 22.6%.
QWhich countries import the most dapsone from India?
The top importing countries for dapsone from India are United States (86.8%), Canada (7.6%), United Kingdom (2.1%), Vietnam (1.7%), South Africa (0.8%). These markets represent the largest demand centres for Indian pharmaceutical exports of dapsone, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for dapsone from India?
The average import transaction value for dapsone from India is $17.7K, with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Dapsone buyer market intelligence
1Buyer Segment Analysis
The importation of Dapsone from India involves various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like J. Knipper & Company and Eversana Life Science Services in the United States fall into this category. They procure Dapsone in bulk to supply pharmacies, hospitals, and healthcare providers. Their purchasing patterns are characterized by large, regular orders to maintain a steady supply chain.
Contract Manufacturers: Torrent Pharma Inc., a significant buyer from the United States, exemplifies this segment. They import Dapsone as an active pharmaceutical ingredient (API) for formulation into finished products. Their procurement is typically large-scale and consistent, aligning with production schedules and market demand.
Retail Chains and Hospital Groups: Marcan Pharmaceuticals Inc. in Canada represents this segment. They import Dapsone to distribute across their network of pharmacies and healthcare facilities. Their purchasing behavior includes regular, moderate-sized orders to meet the needs of their clientele.
Government Procurement: While not explicitly listed among the top buyers, government agencies and international organizations often procure Dapsone through tenders for public health programs. Their purchasing is characterized by large, periodic orders based on public health needs and budget allocations.
Country-Specific Import Regulations
TransData Nexus Dapsone buyer market intelligence
1Country-Specific Import Regulations
Import regulations for Dapsone vary across the top importing countries:
United States:
Regulatory Authority: Food and Drug Administration (FDA).
Import Registration Process: Importers must ensure that Dapsone is FDA-approved and complies with the Federal Food, Drug, and Cosmetic Act. This includes proper labeling, manufacturing standards, and adherence to the Drug Supply Chain Security Act.
Estimated Timeline for Registration: The FDA's drug approval process can take several months to years, depending on the complexity of the application and whether it's a new drug application (NDA) or an abbreviated new drug application (ANDA).
Import Tariff/Duty: According to the Harmonized Tariff Schedule of the United States (HTSUS), Dapsone falls under subheading 3004.90.9214, which is duty-free.
Canada:
Demand Drivers & Market Opportunity
TransData Nexus Dapsone buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Dapsone in importing countries is influenced by several factors:
Disease Prevalence: Dapsone is primarily used to treat leprosy and dermatitis herpetiformis. According to the World Health Organization (WHO), in 2024, there were approximately 200,000 new cases of leprosy reported globally, with significant numbers in countries like India, Brazil, and Indonesia.
Government Healthcare Programs: Many countries have national programs aimed at eradicating leprosy and managing other skin conditions, which include the provision of Dapsone. For instance, the National Leprosy Eradication Programme in India has been instrumental in reducing the disease burden.
Universal Health Coverage Expansion: The global push towards universal health coverage has led to increased access to essential medicines, including Dapsone. Countries expanding their healthcare services are incorporating such medications into their formularies.
WHO Essential Medicines List Procurement: Dapsone is listed on the WHO Model List of Essential Medicines, guiding countries in their procurement decisions. This inclusion underscores its importance and encourages its availability in public health systems.
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
2Canada
Canada emerges as the second largest importing country, achieving a total trade value of $1.7M through 27 shipments. This represents a market share of 7.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Canada has a diverse importer base, with their top importers including:
• MARCAN PHARMACEUTICALS INC. - $1.2M (68.6% of country's total business)
• MARCAN PHARMACEUTICALS INC - $330.3K (19.3% of country's total business)
• AX PHARMACEUTICAL CORP - $84.1K (4.9% of country's total business)
• MARCAN PHARMACEUTICALS INC., - $84.0K (4.9% of country's total business)
Key Insight: Canada demonstrates strong market positioning with an average shipment value of $63.5K, indicating premium pricing strategy compared to the market average of $17.7K.
Canada is a key market for Dapsone imports, representing 7.6% of total trade value.
Primary Market
Secondary Market
3United Kingdom
United Kingdom emerges as the third largest importing country, achieving a total trade value of $485.2K through 15 shipments. This represents a market share of 2.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United Kingdom has a diverse importer base, with their top importers including:
• TILLOMED LABORATORIES LTD - $213.3K (44.0% of country's total business)
• TILLOMED LABORATORIES LTD. - $77.7K (16.0% of country's total business)
Key Insight: United Kingdom demonstrates strong market positioning with an average shipment value of $32.3K, indicating premium pricing strategy compared to the market average of $17.7K.
United Kingdom is a key market for Dapsone imports, representing 2.1% of total trade value.
Primary Market
Secondary Market
4Vietnam
Vietnam emerges as the fourth largest importing country, achieving a total trade value of $393.7K through 150 shipments. This represents a market share of 1.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Vietnam has a diverse importer base, with their top importers including:
• GLOBAL IMPORT AND EXPORT SHIPPING - $118.2K (30.0% of country's total business)
Key Insight: Vietnam demonstrates strong market positioning with an average shipment value of $2.6K, indicating competitive pricing strategy compared to the market average of $17.7K.
Vietnam is a key market for Dapsone imports, representing 1.7% of total trade value.
Primary Market
Secondary Market
5South Africa
South Africa emerges as the fifth largest importing country, achieving a total trade value of $180.0K through 0 shipments. This represents a market share of 0.8% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: South Africa demonstrates strong market positioning with an average shipment value of $180.0K, indicating premium pricing strategy compared to the market average of $17.7K.
South Africa is a key market for Dapsone imports, representing 0.8% of total trade value.
Primary Market
Secondary Market
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Regulatory Authority: Health Canada.
Import Registration Process: Importers must obtain a Drug Establishment License (DEL) and ensure that Dapsone is authorized for sale in Canada. This involves compliance with the Food and Drugs Act and Regulations, including Good Manufacturing Practices (GMP).
Estimated Timeline for Registration: The approval process can range from several months to over a year, depending on the submission type and completeness.
Import Tariff/Duty: Pharmaceutical products, including Dapsone, are typically duty-free under Canada's Customs Tariff.
United Kingdom:
Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).
Import Registration Process: Importers must hold a Wholesale Dealer's License and ensure that Dapsone is licensed in the UK. Compliance with the Human Medicines Regulations 2012 is required.
Estimated Timeline for Registration: The licensing process can take several months, depending on the complexity of the application.
Import Tariff/Duty: As of March 2026, the UK Global Tariff indicates that most pharmaceutical products are duty-free.
Vietnam:
Regulatory Authority: Drug Administration of Vietnam (DAV).
Import Registration Process: Importers must obtain a Marketing Authorization (MA) and ensure compliance with the Law on Pharmacy. This includes GMP certification and product registration.
Estimated Timeline for Registration: The registration process can take 12-24 months, depending on the product and documentation.
Import Tariff/Duty: Pharmaceutical products are generally subject to a 0-5% import duty, depending on the specific product and trade agreements.
South Africa:
Regulatory Authority: South African Health Products Regulatory Authority (SAHPRA).
Import Registration Process: Importers must register the product with SAHPRA, ensuring compliance with the Medicines and Related Substances Act. This includes GMP certification and product evaluation.
Estimated Timeline for Registration: The registration process can take 12-24 months, depending on the product and completeness of the application.
Import Tariff/Duty: Pharmaceutical products are typically duty-free under South Africa's tariff schedule.
Navigating these regulatory landscapes requires thorough preparation and adherence to each country's specific requirements to ensure successful market entry.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Tender-Based Purchasing: Many governments and international organizations procure Dapsone through competitive tendering processes to ensure cost-effectiveness and supply security. The WHO recommends tendering as a strategy to manage pharmaceutical prices and encourage competition.
With 178 buyers across 55 countries, the market for Dapsone is robust. Understanding these demand drivers is essential for stakeholders aiming to optimize their market strategies and meet the healthcare needs of these populations.
TransData Nexus Research · Government and regulatory sourcesMar 2026
$15.14 per unit
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Regulatory Authority: Health Canada.
Import Registration Process: Importers must obtain a Drug Establishment License (DEL) and ensure that Dapsone is authorized for sale in Canada. This involves compliance with the Food and Drugs Act and Regulations, including Good Manufacturing Practices (GMP).
Estimated Timeline for Registration: The approval process can range from several months to over a year, depending on the submission type and completeness.
Import Tariff/Duty: Pharmaceutical products, including Dapsone, are typically duty-free under Canada's Customs Tariff.
United Kingdom:
Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).
Import Registration Process: Importers must hold a Wholesale Dealer's License and ensure that Dapsone is licensed in the UK. Compliance with the Human Medicines Regulations 2012 is required.
Estimated Timeline for Registration: The licensing process can take several months, depending on the complexity of the application.
Import Tariff/Duty: As of March 2026, the UK Global Tariff indicates that most pharmaceutical products are duty-free.
Vietnam:
Regulatory Authority: Drug Administration of Vietnam (DAV).
Import Registration Process: Importers must obtain a Marketing Authorization (MA) and ensure compliance with the Law on Pharmacy. This includes GMP certification and product registration.
Estimated Timeline for Registration: The registration process can take 12-24 months, depending on the product and documentation.
Import Tariff/Duty: Pharmaceutical products are generally subject to a 0-5% import duty, depending on the specific product and trade agreements.
South Africa:
Regulatory Authority: South African Health Products Regulatory Authority (SAHPRA).
Import Registration Process: Importers must register the product with SAHPRA, ensuring compliance with the Medicines and Related Substances Act. This includes GMP certification and product evaluation.
Estimated Timeline for Registration: The registration process can take 12-24 months, depending on the product and completeness of the application.
Import Tariff/Duty: Pharmaceutical products are typically duty-free under South Africa's tariff schedule.
Navigating these regulatory landscapes requires thorough preparation and adherence to each country's specific requirements to ensure successful market entry.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Tender-Based Purchasing: Many governments and international organizations procure Dapsone through competitive tendering processes to ensure cost-effectiveness and supply security. The WHO recommends tendering as a strategy to manage pharmaceutical prices and encourage competition.
With 178 buyers across 55 countries, the market for Dapsone is robust. Understanding these demand drivers is essential for stakeholders aiming to optimize their market strategies and meet the healthcare needs of these populations.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Analysis Methodology
1.Buyer Identification: 178 global importers of Dapsone identified from consignee fields in DGFT shipping bill records.
2.Import Value Analysis: Total import value aggregated from 1,279 individual shipping bill records. Values are FOB in USD.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
4.Geographic Distribution: Buyer imports distributed across 55 destination countries with market share per buyer calculated from capped values.
